CellPhire
OverviewSuggest Edit
CellPhire is a biotechnology company focusing on cell stabilization technology with an emphasis on blood platelets. It focuses on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets. The company develops products that have potential applications in health care fields from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine.
| Type | Private | |
| Founded | 2005 | |
| HQ | Rockville, MD, US | Map |
| Website | cellphire.com |
Recent NewsAll News
- Cellphire Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Thrombosomes in Bleeding Thrombocytopenic Patients
- Cellphire President G. Michael Fitzpatrick Awarded Armed Services Program Lifetime Achievement Award
- Cellphire Begins Phase 2 Trial of Thrombosomes® in Bleeding Thrombocytopenic Patients
Latest Updates
| Employees (est.) (Jul 2021) | 43 | (+8%) |
| Cybersecurity rating | B | More |
Key People/Management at CellPhire
Rafael Jorda
Executive Vice President
G. Michael Fitzpatrick
President
Keith A. Moskowitz
Vice President of Discovery
Thomas S. Dann
Chief Investment Officer
CellPhire Office Locations
CellPhire has an office in Rockville
Rockville, MD, US (HQ)
9430 Key W Ave
CellPhire Financials and Metrics
Summary Metrics
Founding Date | 2005 |
CellPhire Cybersecurity Score
CellPhire Online and Social Media Presence
CellPhire's Trends
CellPhire News and Updates
May 27, 2021
Cellphire Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Thrombosomes in Bleeding Thrombocytopenic Patients
ROCKVILLE, Md., May 27, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across multiple medical indications, announced today that the first patient has been dosed in the company's...
September 23, 2020
Cellphire President G. Michael Fitzpatrick Awarded Armed Services Program Lifetime Achievement Award
ROCKVILLE, Md., Sept. 23, 2020 /PRNewswire/ -- Cellphire, the global leader in long-term stabilization and storage of platelets, is proud to announce that the Armed Services Blood Program (ASBP) has awarded Cellphire President G. Michael Fitzpatrick, PhD, with the 2020 ASBP Lifetime...
March 18, 2020
Cellphire Begins Phase 2 Trial of Thrombosomes® in Bleeding Thrombocytopenic Patients
ROCKVILLE, Md., March 18, 2020 /PRNewswire/ -- Cellphire, Inc., the global leader in long-term stabilization and storage of platelets, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to start a Phase 2 clinical trial of Thrombosomes in...
CellPhire Frequently Asked Questions
When was CellPhire founded?
CellPhire was founded in 2005.
Who are CellPhire key executives?
CellPhire's key executives are Rafael Jorda, G. Michael Fitzpatrick and Keith A. Moskowitz.
How many employees does CellPhire have?
CellPhire has 43 employees.
Who are CellPhire competitors?
Competitors of CellPhire include Viracor Eurofins, Progenity and Epic Sciences.
Where is CellPhire headquarters?
CellPhire headquarters is located at 9430 Key W Ave, Rockville.
Where are CellPhire offices?
CellPhire has an office in Rockville.
How many offices does CellPhire have?
CellPhire has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies